Kirsten Dorans

Kirsten Dorans

Auto-generated profile, based on publicly available information

Kirsten Dorans

Department of Epidemiology, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University , 1440 Canal Street, Suite 1724, New Orleans, LA 70112

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2015 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
MRMary B. Rice
Mary B. Rice
PLPetter L. Ljungman
Petter L. Ljungman
EWElissa H. Wilker
Elissa H. Wilker
KDKirsten S. Dorans
Kirsten S. Dorans
DGDiane R. Gold
Diane R. Gold
MMMurray A. Mittleman
Murray A. Mittleman
Rationale: Few studies have examined associations between long-term exposure to fine particulate matter (PM2.5) and lung function decline in adults. Objectives: To determine if exposure to traffic and PM2.5 is associated with longitudinal changes in lung function in a population-based cohort in the Northeastern United States, where pollution levels are relatively low. Methods: FEV1 and FVC were measured up to two times between 1995 and 2011 among 6,339 participants of the Framingham Offspring or Third Generation studies. We tested associations between residential proximity to a major roadway and PM2.5 exposure in 2001 (estimated by a land-use model using satellite measurements of aerosol optical thickness) and lung function. We examined differences in average lung function using mixed-effects models and differences in lung function decline using linear regression models. Current smokers were excluded. Models were adjusted for age, sex, height, weight, pack-years, socioeconomic status indicators, cohort, time, season, and weather. Measurements and Main Results: Living less than 100 m from a major roadway was associated with a 23.2 ml (95% confidence interval [CI], −44.4 to −1.9) lower FEV1 and a 5.0 ml/yr (95% CI, −9.0 to −0.9) faster decline in FEV1 compared with more than 400 m. Each 2 μg/m3 increase in average of PM2.5 was associated with a 13.5 ml (95% CI, −26.6 to −0.3) lower FEV1 and a 2.1 ml/yr (95% CI, −4.1 to −0.2) faster decline in FEV1. There were similar associations with FVC. Associations with FEV1/FVC ratio were weak or absent. Conclusions: Long-term exposure to traffic and PM2.5, at relatively low levels, was associated with lower FEV1 and FVC and an accelerated rate of lung function decline.

5 June 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
KDKirsten S. Dorans
Kirsten S. Dorans
KMKatherine T. Mills
Katherine T. Mills
YLYang Liu
Yang Liu
JHJiang He
Jiang He
Background: Hypertension is a major risk factor for cardiovascular disease and all‐cause mortality. Compared with prior guidelines, the 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guideline recommends lower blood pressure thresholds for defining hypertension, for initiating antihypertensive medication, and for antihypertensive medication treatment goals. Methods and Results: To better understand potential impacts of the 2017 guideline, we studied trends in mean systolic blood pressure and diastolic blood pressure , prevalence and burden of hypertension, and proportion of controlled hypertension in the US adult population aged ≥20 from 1999 through 2016. We used data from 38 276 adults from the National Health and Nutrition Examination Survey. Age‐standardized prevalence of hypertension decreased from 48.4% in 1999–2000 to 45.4% in 2015–2016. However, absolute burden of hypertension consistently increased, from 87.0 million in 1999–2000 to 108.2 million in 2015–2016. The age‐standardized proportion of controlled hypertension among adults receiving antihypertensive pharmacologic treatment increased from 1999–2000 (25.6%) to 2015–2016 (43.5%). There was not consistent improvement in control throughout the full period among non‐Hispanic blacks, individuals aged ≥60, or those with diabetes mellitus, chronic kidney disease, or high cardiovascular disease risk. Conclusions: Based on the 2017 guideline, from 1999 to 2016, the age‐standardized prevalence of hypertension decreased and the proportion of control among those treated for hypertension improved. However, the absolute hypertension burden increased. Among those treated, the control rate did not consistently improve in all subgroups. These data emphasize the need for continuous efforts in the prevention and control of hypertension in the US general population.

6 May 2016 in Journal of the American Heart Association
Verified
Journal Article
Open access
WLWenyuan Li
Wenyuan Li
EWElissa H. Wilker
Elissa H. Wilker
KDKirsten S. Dorans
Kirsten S. Dorans
MRMary B. Rice
Mary B. Rice
JSJoel Schwartz
Joel Schwartz
MMMurray A. Mittleman
Murray A. Mittleman
Background: Short‐term exposure to elevated air pollution has been associated with higher risk of acute cardiovascular diseases, with systemic oxidative stress induced by air pollution hypothesized as an important underlying mechanism. However, few community‐based studies have assessed this association. Methods and Results: Two thousand thirty‐five Framingham Offspring Cohort participants living within 50 km of the Harvard Boston Supersite who were not current smokers were included. We assessed circulating biomarkers of oxidative stress including blood myeloperoxidase at the seventh examination (1998–2001) and urinary creatinine‐indexed 8‐epi‐prostaglandin F 2α (8‐epi‐ PGF 2α ) at the seventh and eighth (2005–2008) examinations. We measured fine particulate matter ( PM 2.5 ), black carbon, sulfate, nitrogen oxides, and ozone at the Supersite and calculated 1‐, 2‐, 3‐, 5‐, and 7‐day moving averages of each pollutant. Measured myeloperoxidase and 8‐epi‐ PGF 2α were log e transformed. We used linear regression models and linear mixed‐effects models with random intercepts for myeloperoxidase and indexed 8‐epi‐ PGF 2α , respectively. Models were adjusted for demographic variables, individual‐ and area‐level measures of socioeconomic position, clinical and lifestyle factors, weather, and temporal trend. We found positive associations of PM 2.5 and black carbon with myeloperoxidase across multiple moving averages. Additionally, 2‐ to 7‐day moving averages of PM 2.5 and sulfate were consistently positively associated with 8‐epi‐ PGF 2α . Stronger positive associations of black carbon and sulfate with myeloperoxidase were observed among participants with diabetes than in those without. Conclusions: Our community‐based investigation supports an association of select markers of ambient air pollution with circulating biomarkers of oxidative stress.

1 September 2023 in Annals of Internal Medicine
Verified
Journal Article
Closed access
JHJiang He
Jiang He
JBJoshua D. Bundy
Joshua D. Bundy
SGSiyi Geng
Siyi Geng
LTLing Tian
Ling Tian
HHHua He
Hua He
JCJing Chen
Jing Chen
Cardiovascular disease (CVD) mortality is persistently higher in the Black population than in other racial and ethnic groups in the United States. To examine the degree to which social, behavioral, and metabolic risk factors are associated with CVD mortality and the extent to which racial differences in CVD mortality persist after these factors are accounted for. Prospective cohort study. NHANES (National Health and Nutrition Examination Survey) 1999 to 2018. A nationally representative sample of 50 808 persons aged 20 years or older. Data on social, behavioral, and metabolic factors were collected in each NHANES survey using standard methods. Deaths from CVD were ascertained from linkage to the National Death Index with follow-up through 2019. Over an average of 9.4 years of follow-up, 2589 CVD deaths were confirmed. The age- and sex-standardized rates of CVD mortality were 484.7 deaths per 100 000 person-years in Black participants, 384.5 deaths per 100 000 person-years in White participants, 292.4 deaths per 100 000 person-years in Hispanic participants, and 255.1 deaths per 100 000 person-years in other race groups. In a multiple Cox regression analysis adjusted for all measured risk factors simultaneously, several social (unemployment, low family income, food insecurity, lack of home ownership, and unpartnered status), behavioral (current smoking, lack of leisure-time physical activity, and sleep 8 h/d), and metabolic (obesity, hypertension, and diabetes) risk factors were associated with a significantly higher risk for CVD death. After adjustment for these metabolic, behavioral, and social risk factors separately, hazard ratios of CVD mortality for Black compared with White participants were attenuated from 1.54 (95% CI, 1.34 to 1.77) to 1.34 (CI, 1.16 to 1.55), 1.31 (CI, 1.15 to 1.50), and 1.04 (CI, 0.90 to 1.21), respectively. Causal contributions of social, behavioral, and metabolic risk factors to racial and ethnic disparities in CVD mortality could not be established. The Black-White difference in CVD mortality diminished after adjustment for behavioral and metabolic risk factors and completely dissipated with adjustment for social determinants of health in the U.S. population. National Institutes of Health.

2 November 2016 in Obesity
Verified
Journal Article
Open access
PDF file
WLWenyuan Li
Wenyuan Li
KDKirsten S. Dorans
Kirsten S. Dorans
EWElissa H. Wilker
Elissa H. Wilker
MRMary B. Rice
Mary B. Rice
JSJoel Schwartz
Joel Schwartz
MMMurray A. Mittleman
Murray A. Mittleman
Objective: Higher traffic‐related air pollution has been associated with higher body mass index (BMI) among children. However, few studies have assessed the associations among adults.Methods: Participants (N = 2,372) from the Framingham Offspring and Third Generation cohorts who underwent multidetector‐computed tomography scans (2002–2005) were included. Residential‐based proximity to the nearest major roadway and 1‐year average levels of fine particulate matter (PM2.5) air pollution were estimated. BMI was measured at Offspring examination 7 (1998–2001) and Third Generation examination 1 (2002–2005); subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) were measured using multidetector‐computed tomography. Linear regression models were used for continuous BMI, SAT, and VAT and logistic models for the binary indicator of obesity (BMI ≥30 kg/m2), adjusting for demographic variables, individual‐ and area‐level measures of socioeconomic position, and clinical and lifestyle factors.Results: Participants who lived 60 m from a major roadway had 0.37 kg/m2 higher BMI (95% CI: 0.10 to 0.65 kg/m2), 78.4 cm3 higher SAT (95% CI: 4.5 to 152.3 cm3), and 41.8 cm3 higher VAT (95% CI: −4.7 to 88.2 cm3) than those who lived 440 m away.Conclusions: Living closer to a major roadway was associated with higher overall and abdominal adiposity.

26 October 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
KDKirsten S. Dorans
Kirsten S. Dorans
LBLydia A. Bazzano
Lydia A. Bazzano
LQLu Qi
Lu Qi
HHHua He
Hua He
JCJing Chen
Jing Chen
JHJiang He
Jiang He
Importance: Low-carbohydrate diets decrease hemoglobin A1c (HbA1c) among patients with type 2 diabetes at least as much as low-fat diets. However, evidence on the effects of low-carbohydrate diets on HbA1c among individuals with HbA1c in the range of prediabetes to diabetes not treated by diabetes medications is limited.Objective: To study the effect of a behavioral intervention promoting a low-carbohydrate diet compared with usual diet on 6-month changes in HbA1c among individuals with elevated untreated HbA1c.Design, Setting, and Participants: This 6-month randomized clinical trial with 2 parallel groups was conducted from September 2018 to June 2021 at an academic medical center in New Orleans, Louisiana. Laboratory analysts were blinded to assignment. Participants were aged 40 to 70 years with untreated HbA1c of 6.0% to 6.9% (42-52 mmol/mol). Data analysis was performed from November 2021 to September 2022.Interventions: Participants were randomized to a low-carbohydrate diet intervention (target <40 net grams of carbohydrates during the first 3 months; <60 net grams for months 3 to 6) or usual diet. The low-carbohydrate diet group received dietary counseling.Main Outcomes and Measures: Six-month change in HbA1c was the primary outcome. Outcomes were measured at 0, 3, and 6 months.Results: Of 2722 prescreened participants, 962 underwent screening, and 150 were enrolled (mean [SD] age, 58.9 [7.9] years; 108 women [72%]; 88 Black participants [59%]) and randomized to either the low-carbohydrate diet intervention (75 participants) or usual diet (75 participants) group. Six-month data were collected on 142 participants (95%). Mean (SD) HbA1c was 6.16% (0.30%) at baseline. Compared with the usual diet group, the low-carbohydrate diet intervention group had significantly greater 6-month reductions in HbA1c (net difference, –0.23%; 95% CI, –0.32% to –0.14%; P < .001), fasting plasma glucose (–10.3 mg/dL; 95% CI, –15.6 to –4.9 mg/dL; P < .001), and body weight (–5.9 kg; 95% CI, –7.4 to –4.4 kg; P < .001).Conclusions and Relevance: In this randomized clinical trial, a low-carbohydrate dietary intervention led to improvements in glycemia in individuals with elevated HbA1c not taking glucose-lowering medication, but the study was unable to evaluate its effects independently of weight loss. This diet, if sustained, might be a useful dietary approach for preventing and treating type 2 diabetes, but more research is needed.Trial Registration: ClinicalTrials.gov Identifier: NCT03675360